Relationship Genetic Tests Market Report 2024

This Relationship Genetic Tests market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The relationship genetic tests market size has grown exponentially in recent years. It will grow from $3.16 billion in 2023 to $3.87 billion in 2024 at a compound annual growth rate (CAGR) of 22.4%. The historical growth can be attributed to several factors, including increased healthcare expenditure, advancements in genetic research, the expansion of educational programs on genetics, a rising prevalence of infertility, and the growth of awareness campaigns.

The relationship genetic tests market size is expected to see exponential growth in the next few years. It will grow to $8.81 billion in 2028 at a compound annual growth rate (CAGR) of 22.8%. The historical growth can be attributed to several factors, including increased healthcare expenditure, advancements in genetic research, the expansion of educational programs on genetics, a rising prevalence of infertility, and the growth of awareness campaigns.

The growing adoption of personalized medicine is expected to drive the expansion of the relationship genetic tests market. Personalized medicine tailors treatments and healthcare strategies to individual genetic, environmental, and lifestyle factors, aiming for more effective and targeted care. This trend is supported by advancements in genetic research, increased accessibility to genomic data, and a heightened focus on individualized healthcare solutions. Relationship genetic tests play a key role in personalized medicine by providing insights into genetic relationships and familial predispositions. These tests help customize preventive care, treatment plans, and health monitoring strategies based on individual genetic profiles. For example, the Personalized Medicine Coalition reported that in 2022, 12 new customized medications were approved, representing about 34% of all new treatments - a notable increase from previous years. This rise in personalized medicine adoption is fueling growth in the relationship genetic tests market.

Companies in the relationship genetic tests market are concentrating on developing innovative solutions to improve the accuracy and reliability of genetic relationship assessments. DNA relationship testing is a key area of focus, used to determine biological relationships between individuals by analyzing their DNA. For instance, in October 2023, AlphaBiolabs, a UK-based health testing service provider, launched an advanced DNA test designed to identify genetic connections, such as parentage or sibling relationships. This test utilizes cutting-edge technology to achieve high accuracy, with a broad range of genetic markers that enhance result precision and minimize false positives or negatives. It is also designed for rapid processing, delivering results faster than many traditional tests, and includes a comprehensive data analysis platform for clear and detailed reports.

In January 2022, Exact Sciences Corp., a US-based molecular diagnostics company, acquired PreventionGenetics LLC for an undisclosed amount. This acquisition aims to strengthen Exact Sciences' genetic testing portfolio by integrating advanced relationship genetic tests and expanding capabilities in hereditary and genetic disease diagnostics. PreventionGenetics LLC, a US-based company, specializes in various tests for determining biological relationships, including paternity, maternity, and sibling relationships.

Major companies operating in the relationship genetic tests market are Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Cleveland Clinic, Myriad Genetics Inc., Invitae Corporation, Ancestry.com LLC, 23andMe Inc., Ambry Genetics Corporation, Color Health Inc., MyHeritage Ltd., DNA Diagnostics Center Inc., EasyDNA, IntelliGenetics, 23Mofang Biotechnology Co. Ltd., Mapmygenome India Ltd., AlphaBiolabs Ltd., Living DNA Ltd., Pathway Genomics Corporation, Anglia DNA Services Ltd., African Ancestry Inc., Canadian DNA Services Inc., DNA Family Check.

North America was the largest region in the relationship genetic tests market in 2023. The regions covered in the relationship genetic tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the relationship genetic tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A relationship genetic test is a genetic analysis designed to determine biological relationships between individuals. These tests evaluate specific genetic markers to establish or confirm relationships such as parent-child, sibling, or other familial connections. By comparing the DNA of the individuals involved, relationship genetic tests identify genetic markers that indicate a biological relationship, offering a high level of accuracy in confirming familial ties.

The main types of relationship genetic tests include the Sibling DNA test, the Grandparentage test, the Genetic Reconstruction test, and others. The Sibling DNA test assesses the likelihood that two individuals share one or both parents and is often used when the alleged parents are not available for testing. Samples for these tests can include saliva, urine, or blood. Applications of these tests include direct-to-consumer services and legal service tests.

The relationship genetic tests market research report is one of a series of new reports that provides relationship genetic tests market statistics, including relationship genetic tests industry global market size, regional shares, competitors with a relationship genetic tests market share, detailed relationship genetic tests market segments, market trends and opportunities, and any further data you may need to thrive in the relationship genetic tests industry. This relationship genetic tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The relationship genetic tests market consists of revenues earned by entities by providing services such as sample collection, genetic analysis, and consultation services and related genetic testing kits, laboratory analysis tools, result reporting systems, and genetic databases. The market value includes the value of related goods sold by the service provider or included within the service offering. The relationship genetic test market also includes sales of polymerase chain reaction (PCR) machines, capillary electrophoresis systems, next-generation sequencing (NGS) platforms, microarray scanners, real-time PCR systems, DNA sequencers, and gel electrophoresis systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.